Publication Name	World Journal of Pharmacology
Manuscript ID	11441
Country	United Kingdom

Received	2014-05-21 21:14
Peer-Review Started	2014-05-21 22:45
To Make the First Decision	2014-06-06 11:00
Return for Revision	2014-06-16 11:36
Revised	2014-07-14 19:48
Second Decision	2014-10-27 16:58
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-10-27 17:17
Articles in Press	2014-10-27 17:17
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-11-28 17:54
Publish the Manuscript Online	2014-12-12 11:14

ISSN	2220-3192 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Systematic Reviews
Article Title	Association of serum bilirubin and non-alcoholic fatty liver disease: a feasible therapeutic avenue?
Manuscript Source	Invited Manuscript
All Author List	Mohamed S Anwar, John F Dillon and Michael H Miller
Funding Agency and Grant Number
Corresponding Author	Dr. Mohamed Anwar, Gut Group, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, Nethergate, Dundee DD1 9SY, United Kingdom. mohamed-anwar@doctors.org.uk
Key Words	Review; Systematic; Bilirubin; Hyperbilirubinemia; Anti-oxidants; Adult; Non-alcoholic fatty liver disease
Core Tip	This systematic review summarises and highlights the deficiencies in the current studies on the association of serum bilirubin with non-alcoholic fatty liver disease (NAFLD). It explores the potential underpinning of the mechanistic association of NAFLD with bilirubin. Potential novel therapeutic avenues of bilirubin are explored in NAFLD, a common condition with oxidative damage as a core pathogenetic factor. Although this area of study is still in its infancy, this review is a timely summary of current key studies in this subject area and provides an up to date thought perspective with focus on future direction and potential therapeutic application.
Publish Date	2014-12-12 11:14
Citation	Anwar MS, Dillon JF, Miller MH. Association of serum bilirubin and non-alcoholic fatty liver disease: A feasible therapeutic avenue? World J Pharmacol 2014; 3(4): 209-216
URL	http://www.wjgnet.com/2220-3192/full/v3/i4/209.htm
DOI	http://dx.doi.org/10.5497/wjp.v3.i4.209

Full Article (PDF)	WJP-3-209.pdf
Full Article (Word)	WJP-3-209.doc
Manuscript File	11441-Review.docx
Answering Reviewers	11441-Answering reviewers.pdf
Copyright License Agreement	11441-Copyright assignment.pdf
Peer-review Report	11441-Peer review(s).pdf
Scientific Misconduct Check	11441-CrossCheck.jpg
Scientific Editor Work List	11441-Scientific editor work list.pdf